We’re pretty happy with Newsday’s coverage of how patients taking GLP-1 drugs will be affected by...
Scott helps North Texas understand the new GLP-1 landscape
Patients in the Dallas area are feeling the sticker shock of the end of the GLP-1 shortages. APC's Scott Brunner explains to ABC News that it's not a local thing, as well as why it's happening.
"I've heard of patients having tantrums at the pharmacy counter when they see the price tag of the name-brand drug they have been prescribed," said Brunner.
It's (as you know!) not just patients feeling the shock. Pharmacies, the story explains, are often not even breaking even with mass-produced GLP-1s — some smaller indy pharmacies are even sending patients to chains rather than lose money by dispensing these drugs.
